Top Rounded Image

Biological joints could replace artificial joints one day

Researchers have found a way to create these biological joints in animals, and they believe biological joint replacements for humans aren't far away
Researchers have found a way to create these biological joints in animals, and they believe biological joint replacements for humans aren't far away.

Artificial joint replacements can drastically change a patient's quality of life. Painful, arthritic knees, shoulders and hips can be replaced with state-of-the-art metal or ceramic implants, eliminating pain and giving a person a new lease on life. But, what if, instead of metal and plastic, doctors were able to take a patient's cells and grow an entirely new joint, replacing the old one with a fully functional biological joint? A team of University of Missouri and Columbia University researchers have found a way to create these biological joints in animals, and they believe biological joint replacements for humans aren't far away.

In a study published this fall in The Lancet, James Cook, a researcher in the MU College of Veterinary Medicine and Dept of Orthopaedic Surgery participated on a research team that created new cartilage in animals using a biological "scaffold" in the animals' joints. Cook assisted with the implant design and performed the surgeries to implant the biologic joint replacements. The study was led by Jeremy Mao of Columbia University.

The scaffold was implanted in rabbits with a surgical technique currently used for shoulder replacement in humans. The surgery removes the entire humeral head, or the ball part of the ball-and-socket shoulder joints. The scaffolds are infused with a growth factor, which encourages the host's own cells, including stem cells, to become cartilage and bone cells. The advantage to this technique is that it avoids the need to harvest and implant cells, which requires multiple surgeries.
"The device was designed with both biological and mechanical factors in mind," Cook said. "It is unique in design and composition and in how it stimulates the body's own cells. This is the first time we have seen cartilage regeneration using this type of scaffold."

The study found that the rabbits given the infused scaffolds resumed weight-bearing and functional use of their limbs faster and more consistently than those without. Four months later, cartilage had formed in the scaffolds creating a new, functional cartilage surface for the humeral head. The team observed no complications or adverse events after surgery; the new tissue regeneration was associated with excellent limb use and shoulder health, indicating the procedure is both safe and effective.

"If we continue to prove the safety and efficacy of this biologic joint replacement strategy, then we can get FDA approval for use of this technology for joint replacements in people," Cook said. "We are still in the early phases of this process, but this study gives a big boost to its feasibility."

"We are continuing our concerted efforts in this arena," Cook said. "Our goal at Mizzou's Comparative Orthopaedic Laboratory is to do away with metal and plastic joints, and instead, regenerate a fully functional biologic joint for everyone who needs one. We think this is the future of orthopaedics and we hope that future is starting here and now."

Dr Matt Dalby

Dr Matt Dalby

Dr. Matt Dalby is Reader in Cell Engineering at the Centre for Cell Engineering, University of Glasgow. He has published around 65 papers on bone tissue engineering, biomaterials and nanobioscience including in Nature Materials. His research is funded by BBSRC, EPSRC and the Chief Scientist's Office. As well as his basic research he has published two patents and has won over ten prizes including the NEXXUS West of Scotland young life scientist of the year, the Tissue and Cell Engineering Society’s New Investigator Prize and the Society for Experimental Biology's President’s Medal. He is co-founder (along with orthopaedic surgeon, Mr Dominic Meek) of the Glasgow Orthopaedic Research Initiative, GLORI).

At the Institute of Nanotechnology’s forthcoming Conference, Advanced Technologies for an Ageing Population, to be held in Glasgow on 23-24 March 2011, Dr. Dalby’s presentation will focus on the use of nanoscale topography to influence mesenchymal stem cells with particular focus on targeted differentiation and the retention of stem cell phenotype which has important consequences for the future engingineering of biological implants The talk will also consider use of nanoscale topography as a way of understanding mesenchymal stem cell mechanotransduction and will provide an overview of new material strategies for the control of mesenchymal stem cells.

Further Information and Registration >>

Source: - 5 January 2011 /...

Previous Story: New method permits widespread electronics use
Next Story: Tiny trojan horses deliver a cancer drug to cell nuclei

Bookmark and Share

Leave a Comment

The Institute of Nanotechnology puts significant effort into ensuring that the information provided on its news pages is accurate and up-to-date. However, we cannot guarantee absolute accuracy. Consequently, the Institute of Nanotechnology disclaims any and all responsibility for inaccuracy, omission or any kind of deficiency in relation to the news items and articles hosted herein.

Bottom Rounded Image